Clinical studies recruiting near Spokane

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Medical Oncology Associates, PS (dba Summit Cancer Centers) · Merck Sharp & Dohme LLC · NCT06136559 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Providence Sacred Heart Medical Center and Children's Hospit · National Cancer Institute (NCI) · NCT05099003 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Providence Sacred Heart Medical Center and Children's Hospit · National Cancer Institute (NCI) · NCT06172296 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Providence Sacred Heart Medical Center and Children's Hospit · Children's Oncology Group · NCT06368817 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Providence Sacred Heart Medical Center and Children's Hospit · National Cancer Institute (NCI) · NCT05691478 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Velocity Clinical Research - Spokane · Amgen · NCT07037433 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Principle Research Solutions · Eli Lilly and Company · NCT07415044 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Cancer Care Northwest - Spokane South · Alliance for Clinical Trials in Oncology · NCT07091617 Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Phase 3 · TG Therapeutics Investigational Trial Site · TG Therapeutics, Inc. · NCT05877963 A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorecta
Phase 1 · Medical Oncology Associates · Hoffmann-La Roche · NCT04929223 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Providence Sacred Heart Medical Center and Children's Hospit · Children's Oncology Group · NCT04322318 A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymph
Phase 3 · Medical Oncology Associates, PS · Loxo Oncology, Inc. · NCT05254743 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0097 · Celgene · NCT05519085 Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Phase 2 · Spokane Urology · CG Oncology, Inc. · NCT06567743 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Providence Medical Research Center · Boehringer Ingelheim · NCT06531824 Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treat
Phase 2 · Spokane Treatment Center · Washington State University · NCT06323837 A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Spokane Urology · Janssen Research & Development, LLC · NCT06319820 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Medical Oncology Associates /ID# 247003 · AbbVie · NCT04928846 ERP to Improve Functioning in Veterans With OCD
NA · Spokane VA Medical Center, Spokane, WA · VA Office of Research and Development · NCT05240924 A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Phase 1 · Summit Cancer Center · Compass Therapeutics · NCT06150664 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 A Prospective Total Joint Surgery Registry to Monitor Short- and Long-Term Clinical Outcomes
Phase N/A · Spokane Joint Replacement Center · Spokane Joint Replacement Center · NCT06687109 A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atop
Phase 3 · Dermatology Specialists of Spokane · Organon and Co · NCT07265479 Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder
Phase 2 · Spokane Urology · Protara Therapeutics · NCT05951179 BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer
Phase 3 · Multicare Cancer Institute Deaconess Medical Office Building · BeOne Medicines · NCT07492641 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Cancer Care Northwest - Spokane South · Canadian Cancer Trials Group · NCT06592924 Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach
EARLY_Phase 1 · Washington State University College of Pharmacy and Pharmace · Washington State University · NCT06693960 A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H
Phase 2/Phase 3 · MultiCare Rockwood Clinic /ID# 255951 · AbbVie · NCT06345339

Look up another city

Look up another condition